使用维替泊芬光动力疗法治疗脉络膜血管瘤：病例报告
Choroidal hemangioma treated with photodynamic therapy using verteporfin: report of a case.
作者信息
Nicolò M, Ghiglione D, Polizzi A, Calabria G
机构信息
Department of Neurology, University Eye Clinic of Genova, Genova, Italy.
出版信息
Eur J Ophthalmol. 2003 Aug-Sep;13(7):656-61. doi: 10.1177/112067210301300711.
PURPOSE
To report the results of treatment of circumscribed choroidal hemangioma with a single application of photodynamic therapy (PDT) with verteporfin according to the Treatment of Age-related Macular Degeneration with Photodynamic Therapy study.
METHODS
A 44-year-old man with unilateral decreased vision and macular subretinal fluid secondary to a circumscribed choroidal hemangioma diagnosed by fluorescein and indocyanine green angiography and ultrasonography underwent PDT with verteporfin therapy.
RESULTS
One year after PDT, subretinal fluid was absent and visual acuity improved.
CONCLUSIONS
The results obtained in this case are in keeping with previously reported results; however, future randomized studies are necessary to evaluate and standardize different infusion times in order to obtain maximum efficacy of treatment.
目的
根据光动力疗法治疗年龄相关性黄斑变性研究，报告单次应用维替泊芬光动力疗法（PDT）治疗局限性脉络膜血管瘤的结果。
方法
一名44岁男性，因荧光素和吲哚菁绿血管造影及超声检查诊断为局限性脉络膜血管瘤继发单侧视力下降和黄斑下视网膜积液，接受了维替泊芬光动力疗法。
结果
光动力疗法后一年，视网膜下积液消失，视力提高。
结论
该病例的结果与先前报道的结果一致；然而，未来需要进行随机研究，以评估和规范不同的输注时间，从而获得最大的治疗效果。
Zotero 插件